NewsRamp Health & Wellness Podcast

Lexaria Bioscience, Carmed Pharmaceuticals, Voyageur Pharmaceuticals, and more share updates on research, market expansion, clinical trials, and resources in the healthcare industry.

Hulu's 'Paradise' stuns with character death from preeclampsia; ABVC BioPharma reports huge asset increase driven by acquisitions in Asia. HCN Global launches health series; Sino Biological launches antigens for influenza vaccines.

NeuroOne appoints David Wambeke as CBO and launches drug delivery program, First Steps opens early intervention center, Celebrity Smiles offers comprehensive dental services, Smiles for Life campaign raises funds, NSPC ranks #1 in neurosurgery, Dr. Sajad Zalzala launches scholarship for healthcare professionals.

Dr. Arash Bereliani's book 'What About Her Heart?' sheds light on women's heart health challenges, emphasizing awareness, prevention, and empowerment.

Rejuvience Med Spa Scottsdale introduces a non-surgical treatment combining Tixel Eye Lift, Procell Microchanneling, and AnteAGE P.E.A.R.L. to combat aging signs effectively with minimal downtime for individuals aged 50 and above.

Friendly Recovery Center's blog explains how anxiety can manifest physical symptoms, debunking misconceptions and offering evidence-based insights.

Elevated Estates offers affordable Alzheimer's care, UCLA researchers combat fuel shortages in cancer immunotherapy, CBT300 aims to tackle cancer recurrence, and The Harvest Table expands its wellness products in the U.S. market.

NRx Pharmaceuticals advances NRX-100 for depression, HeartMath showcases heart-focused techniques, medical expenses cause bankruptcies, and clinics offer specialized treatments and services across various locations.

Ketryx sees record momentum in 2026 with top MedTech companies adopting its AI-native compliance platform. Kairos Pharma acquires assets to expand oncology pipeline, while Medicare Advantage insurers face enrollment slowdown.

Soligenix receives positive recommendation in Europe for SGX945, while Quoin Pharmaceuticals highlights Netherton Syndrome campaign.